Nrf2, the Major Regulator of the Cellular Oxidative Stress Response, is Partially Disordered.
Keap1
Nrf2
circular dichroism
hydrogen/deuterium exchange
intrinsically disordered
mass spectrometry
nuclear magnetic resonance spectroscopy
oxidative stress
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Jul 2021
11 Jul 2021
Historique:
received:
18
06
2021
revised:
06
07
2021
accepted:
08
07
2021
entrez:
24
7
2021
pubmed:
25
7
2021
medline:
30
7
2021
Statut:
epublish
Résumé
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription regulator that plays a pivotal role in coordinating the cellular response to oxidative stress. Through interactions with other proteins, such as Kelch-like ECH-associated protein 1 (Keap1), CREB-binding protein (CBP), and retinoid X receptor alpha (RXRα), Nrf2 mediates the transcription of cytoprotective genes critical for removing toxicants and preventing DNA damage, thereby playing a significant role in chemoprevention. Dysregulation of Nrf2 is linked to tumorigenesis and chemoresistance, making Nrf2 a promising target for anticancer therapeutics. However, despite the physiological importance of Nrf2, the molecular details of this protein and its interactions with most of its targets remain unknown, hindering the rational design of Nrf2-targeted therapeutics. With this in mind, we used a combined bioinformatics and experimental approach to characterize the structure of full-length Nrf2 and its interaction with Keap1. Our results show that Nrf2 is partially disordered, with transiently structured elements in its Neh2, Neh7, and Neh1 domains. Moreover, interaction with the Kelch domain of Keap1 leads to protection of the binding motifs in the Neh2 domain of Nrf2, while the rest of the protein remains highly dynamic. This work represents the first detailed structural characterization of full-length Nrf2 and provides valuable insights into the molecular basis of Nrf2 activity modulation in oxidative stress response.
Identifiants
pubmed: 34299054
pii: ijms22147434
doi: 10.3390/ijms22147434
pmc: PMC8305528
pii:
doi:
Substances chimiques
Intrinsically Disordered Proteins
0
KEAP1 protein, human
0
Kelch-Like ECH-Associated Protein 1
0
NF-E2-Related Factor 2
0
NFE2L2 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Natural Sciences and Engineering Research Council of Canada
ID : RGPIN-2019-06711
Organisme : Natural Sciences and Engineering Research Council of Canada
ID : RGPIN-2018-04243
Références
Curr Opin Struct Biol. 2007 Feb;17(1):3-14
pubmed: 17250999
Protein Sci. 2007 Nov;16(11):2510-8
pubmed: 17905836
Biochem Soc Trans. 2020 Apr 29;48(2):379-397
pubmed: 32311028
Curr Opin Struct Biol. 2009 Feb;19(1):31-8
pubmed: 19157855
Biopolymers. 2008 May;89(5):392-400
pubmed: 17896349
J Mol Biol. 2015 Feb 27;427(4):982-996
pubmed: 25534081
Nat Rev Mol Cell Biol. 2015 Jan;16(1):18-29
pubmed: 25531225
Nat Rev Cancer. 2012 Jul 19;12(8):564-71
pubmed: 22810811
Structure. 2003 Nov;11(11):1453-9
pubmed: 14604535
Mol Cell Biol. 2003 Nov;23(22):8137-51
pubmed: 14585973
Oxid Med Cell Longev. 2016;2016:1958174
pubmed: 26697129
Mol Cell Biol. 2005 Sep;25(18):8044-51
pubmed: 16135796
J Am Soc Mass Spectrom. 2012 Jun;23(6):1003-10
pubmed: 22476891
Biochemistry. 2007 Nov 13;46(45):13120-30
pubmed: 17929838
Anal Chim Acta. 2012 Apr 6;721:7-21
pubmed: 22405295
Nucleic Acids Res. 2018 Jul 2;46(W1):W329-W337
pubmed: 29860432
Chem Soc Rev. 2011 Mar;40(3):1224-34
pubmed: 21173980
Urol Oncol. 2014 Aug;32(6):806-14
pubmed: 24837013
Biochem J. 2007 Jun 15;404(3):459-66
pubmed: 17313370
Mol Cell Biol. 2004 Aug;24(16):7130-9
pubmed: 15282312
Arch Toxicol. 2011 Apr;85(4):241-72
pubmed: 21365312
Genes Dev. 2013 Oct 15;27(20):2179-91
pubmed: 24142871
Antioxid Redox Signal. 2013 Jan 1;18(1):91-3
pubmed: 22703241
Drug Metab Rev. 2006;38(4):769-89
pubmed: 17145701
Biochem Biophys Res Commun. 1997 Jul 18;236(2):313-22
pubmed: 9240432
J Biol Chem. 2004 Jul 23;279(30):31556-67
pubmed: 15143058
Biochem Biophys Res Commun. 2014 Sep 26;452(3):554-9
pubmed: 25172665
J Surg Oncol. 2010 May 1;101(6):500-6
pubmed: 20213688
J Mol Biol. 2004 Mar 26;337(3):635-45
pubmed: 15019783
Methods Mol Biol. 2004;278:313-52
pubmed: 15318002
Biochim Biophys Acta. 2010 Apr;1804(4):996-1010
pubmed: 20100603
Oncogene. 2013 Aug 8;32(32):3765-81
pubmed: 22964642
Medchemcomm. 2016 Nov 17;8(2):286-294
pubmed: 30108745
Antioxidants (Basel). 2020 Feb 25;9(3):
pubmed: 32106613
Mol Cell. 2009 Jun 26;34(6):663-73
pubmed: 19560419
Pharmacol Res. 2008 Nov-Dec;58(5-6):262-70
pubmed: 18838122
Int J Mol Sci. 2021 Apr 28;22(9):
pubmed: 33924958
Biochemistry. 2005 Mar 29;44(12):4919-25
pubmed: 15779919
Curr Opin Struct Biol. 2008 Dec;18(6):756-64
pubmed: 18952168
J Mol Biol. 1999 Oct 22;293(2):321-31
pubmed: 10550212
EMBO J. 2006 Aug 9;25(15):3605-17
pubmed: 16888629
Mol Cell Biol. 2005 Dec;25(24):10895-906
pubmed: 16314513
Mol Cell Biol. 2006 Apr;26(8):2887-900
pubmed: 16581765
Cancer Res. 2012 Nov 1;72(21):5537-46
pubmed: 22964583
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9926-30
pubmed: 7937919
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
Antioxid Redox Signal. 2018 Dec 10;29(17):1727-1745
pubmed: 28899199
Annu Rev Pharmacol Toxicol. 2013;53:401-26
pubmed: 23294312
FEBS Lett. 2015 Sep 14;589(19 Pt A):2433-40
pubmed: 26073260
J Mol Biol. 2013 Mar 25;425(6):1011-27
pubmed: 23318954
Neoplasia. 2011 Sep;13(9):864-73
pubmed: 21969819
Curr Opin Struct Biol. 2002 Feb;12(1):54-60
pubmed: 11839490
Biochemistry. 2011 Feb 8;50(5):715-26
pubmed: 21182262
Genes Cells. 2011 Feb;16(2):123-40
pubmed: 21251164
Genes Cells. 2001 Oct;6(10):857-68
pubmed: 11683914
Bioinformatics. 2013 Feb 1;29(3):398-9
pubmed: 23233655
Biofactors. 2015 Jan-Feb;41(1):52-7
pubmed: 25728635
Pathol Int. 2015 May;65(5):210-9
pubmed: 25707882
Protein Sci. 2010 Sep;19(9):1783-95
pubmed: 20665695
Mol Cancer Ther. 2010 Feb;9(2):336-46
pubmed: 20124447
Oxid Med Cell Longev. 2017;2017:9237263
pubmed: 29104732
Mol Cell. 2006 Mar 3;21(5):689-700
pubmed: 16507366
Trends Mol Med. 2016 Jul;22(7):578-593
pubmed: 27263465
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13568-73
pubmed: 18757741
Genes Dev. 1999 Jan 1;13(1):76-86
pubmed: 9887101
Mol Cell Biol. 2014 Mar;34(5):832-46
pubmed: 24366543
Redox Biol. 2013 Jan 18;1:45-9
pubmed: 24024136
Oncogene. 2013 Jan 24;32(4):514-27
pubmed: 22370642
J Biol Chem. 2006 Aug 25;281(34):24756-68
pubmed: 16790436
FEBS J. 2005 Oct;272(20):5129-48
pubmed: 16218947
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15259-64
pubmed: 23986495
Exerc Sport Sci Rev. 2013 Jul;41(3):162-8
pubmed: 23558695
Oxid Med Cell Longev. 2013;2013:104308
pubmed: 23691261
Mol Cell Biol. 2009 May;29(10):2658-72
pubmed: 19273602
Nature. 2012 Sep 27;489(7417):519-25
pubmed: 22960745
Trends Biochem Sci. 2002 Oct;27(10):527-33
pubmed: 12368089
Cancer Res. 2013 May 15;73(10):3097-108
pubmed: 23612120
Clin Cancer Res. 2009 May 15;15(10):3423-32
pubmed: 19417020
Protein Sci. 2001 Jul;10(7):1353-62
pubmed: 11420437